BlackRock, Inc. 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 2:27 pm Purchase | 2023-12-31 | 13G | Kura Oncology, Inc. KURA | BlackRock Inc. BLK | 7,315,647 9.800% | 2,152,811 (+41.70%) | Filing |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | BlackRock Inc. BLK | 5,162,836 7.600% | 67,810 (+1.33%) | Filing |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Kura Oncology, Inc. KURA | BlackRock Inc. BLK | 5,095,026 7.700% | 163,070 (+3.31%) | Filing |
| 2021-01-29 5:23 pm Purchase | 2020-12-31 | 13G | Kura Oncology, Inc. KURA | BlackRock Inc. BLK | 4,931,956 7.600% | 1,938,204 (+64.74%) | Filing |
| 2020-02-05 12:16 pm Purchase | 2019-12-31 | 13G | Kura Oncology, Inc. KURA | BlackRock Inc. BLK | 2,993,752 6.600% | 583,773 (+24.22%) | Filing |